Richard A. Miller MD - 02 Jun 2022 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Role
President and CEO, Director
Signature
/s/ Leiv Lea, as Attorney-in-Fact for Richard A. Miller
Issuer symbol
CRVS
Transactions as of
02 Jun 2022
Net transactions value
+$5,797
Form type
4
Filing time
06 Jun 2022, 18:43:22 UTC
Previous filing
01 Apr 2022
Next filing
10 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRVS Common Stock Purchase $4,733 +4,830 +0.36% $0.9800 1,338,345 02 Jun 2022 By Trust F1
transaction CRVS Common Stock Purchase $165 +170 +0.01% $0.9700 1,338,515 02 Jun 2022 By Trust F1
transaction CRVS Common Stock Purchase $899 +890 +0.07% $1.01 1,339,405 06 Jun 2022 By Trust F1
holding CRVS Common Stock 35,714 02 Jun 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.